Mukka Proteins Gains 6.64%: 3 Key Factors Driving the Week’s Momentum

1 hour ago
share
Share Via
Mukka Proteins Ltd delivered a strong weekly performance, rising 6.64% from ₹22.75 to ₹24.26 between 15 and 19 June 2026, comfortably outperforming the Sensex’s 2.35% gain over the same period. The stock’s trajectory was shaped by a notable shift in technical momentum, an upgrade in investment rating from Sell to Hold, and mixed but improving financial results. Despite some short-term profit-taking towards week-end, the stock’s overall trend reflected cautious optimism amid a complex market backdrop.

Key Events This Week

15 Jun: Stock opens strong at ₹24.17, up 6.24%

16 Jun: Technical momentum shifts; Mojo Grade upgraded to Hold

17 Jun: Mild bullish technical outlook confirmed with 4.72% gain

18-19 Jun: Minor corrections amid mixed volume and market volatility

Week Open
Rs.22.75
Week Close
Rs.24.26
+6.64%
Week High
Rs.25.31
vs Sensex
+4.29%

15 June 2026: Strong Opening with 6.24% Gain

Mukka Proteins began the week on a robust note, closing at ₹24.17, a 6.24% increase from the previous Friday’s close of ₹22.75. This surge was accompanied by a volume of 33,794 shares, signalling renewed investor interest. The Sensex also advanced 1.19% to 35,764.67, but Mukka Proteins clearly outpaced the broader market. The stock’s intraday range between ₹23.50 and ₹24.54 reflected heightened volatility and buying enthusiasm, setting the tone for the week ahead.

16 June 2026: Technical Momentum Shift and Mojo Upgrade

The momentum continued on 16 June as Mukka Proteins closed at ₹25.31, up 4.72% on the day with a significant volume spike to 117,058 shares. This price action coincided with a notable shift in technical indicators, moving from a sideways to a mildly bullish trend. Key weekly indicators such as MACD and Bollinger Bands turned positive, while the Know Sure Thing (KST) oscillator also supported upward momentum. These developments prompted MarketsMOJO to upgrade the stock’s Mojo Grade from Sell to Hold, reflecting improved technical and fundamental outlooks despite ongoing challenges.

Financially, the company reported strong quarterly results with net sales for the past six months reaching ₹1,034.11 crores, a 51.03% increase, and profit after tax rising 84.4% to ₹20.62 crores. However, longer-term growth remains modest, and the company carries a high debt burden with a Debt to EBITDA ratio of 6.80 times, tempering enthusiasm.

Our latest weekly pick is live! This Large Cap from Diamond & Gold Jewellery comes with clear entry and exit targets. See the detailed report with target price now!

  • - Clear entry/exit targets
  • - Target price revealed
  • - Detailed report available

View Target Price Report →

17 June 2026: Mild Bullish Outlook Confirmed

On 17 June, Mukka Proteins maintained its positive momentum, closing at ₹24.98, a slight decline of 1.30% from the previous day but still reflecting strength relative to the Sensex’s 0.52% gain. The stock’s intraday volatility was notable, with a high of ₹25.84 and a low of ₹23.20. Technical indicators continued to signal a mild bullish trend, with weekly MACD and Bollinger Bands supporting upward momentum, while daily moving averages suggested some short-term consolidation.

The upgraded Mojo Score of 53.0 and Hold rating reinforced the cautious optimism. Despite the stock trading below its 52-week high of ₹31.20, the recent price gains and technical improvements suggest a recovery phase within a broader trading range. Volume moderated to 47,574 shares, indicating a more measured trading environment.

18-19 June 2026: Minor Corrections Amid Mixed Signals

The final two trading days saw some profit-taking and minor price corrections. On 18 June, the stock declined 1.88% to ₹24.51 on lower volume of 22,388 shares, while the Sensex continued to rise 0.44%. On 19 June, Mukka Proteins closed at ₹24.26, down 1.02%, with volume further declining to 17,641 shares. The Sensex reversed course, falling 0.30% to 36,174.54.

These moves reflected a cautious market mood and the stock’s struggle to break decisively above resistance near ₹25-₹26. Technical indicators such as daily moving averages and monthly Bollinger Bands remained mildly bearish, suggesting that while medium-term momentum is positive, short-term volatility and consolidation are likely to persist.

Holding Mukka Proteins Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Date Stock Price Day Change Sensex Day Change
2026-06-15 Rs.24.17 +6.24% 35,764.67 +1.19%
2026-06-16 Rs.25.31 +4.72% 35,939.94 +0.49%
2026-06-17 Rs.24.98 -1.30% 36,125.82 +0.52%
2026-06-18 Rs.24.51 -1.88% 36,284.69 +0.44%
2026-06-19 Rs.24.26 -1.02% 36,174.54 -0.30%

Key Takeaways

Positive Signals: Mukka Proteins outperformed the Sensex by 4.29% over the week, driven by a technical momentum shift from sideways to mildly bullish. The upgrade to a Hold rating by MarketsMOJO reflects improved technical indicators such as MACD, Bollinger Bands, and KST. Quarterly financials showed strong sales growth of 51.03% and an 84.4% rise in profit after tax, supporting the positive sentiment.

Cautionary Notes: Despite short-term gains, the stock remains below its 52-week high of ₹31.20 and faces resistance near ₹25-₹26. Daily moving averages and monthly Bollinger Bands signal mild bearishness, indicating potential consolidation or correction phases. The company’s high debt level (Debt to EBITDA of 6.80) and modest long-term growth rates temper enthusiasm. Low institutional ownership and micro-cap status add to volatility and risk.

Conclusion

Mukka Proteins Ltd’s week was characterised by a clear technical turnaround and an upgrade in investment rating, underpinned by strong recent financial results. The stock’s 6.64% weekly gain and outperformance versus the Sensex highlight renewed investor interest and momentum. However, mixed technical signals and structural financial challenges suggest that the stock remains in a phase of cautious consolidation. Investors should monitor key resistance levels and volume trends closely to assess whether the mild bullish trend can sustain beyond short-term fluctuations. The Hold rating reflects this balanced outlook, recognising both the potential for further gains and the risks inherent in the company’s profile.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Mukka Proteins Ltd is Rated Sell by MarketsMOJO
Jun 09 2026 10:10 AM IST
share
Share Via
Mukka Proteins Ltd is Rated Sell
May 28 2026 10:10 AM IST
share
Share Via
Mukka Proteins Ltd is Rated Sell by MarketsMOJO
May 17 2026 10:10 AM IST
share
Share Via
Are Mukka Proteins Ltd latest results good or bad?
May 16 2026 07:31 PM IST
share
Share Via